These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20400197)

  • 1. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study.
    Omland LH; Krarup H; Jepsen P; Georgsen J; Harritshøj LH; Riisom K; Jacobsen SE; Schouenborg P; Christensen PB; Sørensen HT; Obel N;
    J Hepatol; 2010 Jul; 53(1):36-42. PubMed ID: 20400197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study.
    Omland LH; Jepsen P; Weis N; Christensen PB; Laursen AL; Nielsen H; Krarup H; Sørensen HT; Obel N
    J Viral Hepat; 2010 Apr; 17(4):261-8. PubMed ID: 19709359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study.
    Omland LH; Jepsen P; Skinhøj P; Jørgensen HL; Münster AM; Bangsborg J; Fenger M; Sørensen HT; Obel N
    HIV Med; 2009 Feb; 10(2):65-71. PubMed ID: 19018878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study.
    Omland LH; Christensen PB; Krarup H; Jepsen P; Weis N; Sørensen HT; Obel N;
    PLoS One; 2011; 6(7):e22476. PubMed ID: 21789259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.
    Just SA; Grau K; Georgsen J; Weis N; Cowan S; Groenbaek K; Krarup H; Christensen PB;
    Transfusion; 2012 Mar; 52(3):582-8. PubMed ID: 21883266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
    Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
    J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of acute symptomatic hepatitis type C.
    Wawrzynowicz-Syczewska M; Kubicka J; Lewandowski Z; Boroń-Kaczmarska A; Radkowski M
    Infection; 2004 Jun; 32(3):138-43. PubMed ID: 15188072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study.
    Kielland KB; Skaug K; Amundsen EJ; Dalgard O
    J Hepatol; 2013 Jan; 58(1):31-7. PubMed ID: 22960427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No impact of hepatitis C virus infection on mortality among drug users during the first decade after seroconversion.
    Grady B; van den Berg C; van der Helm J; Schinkel J; Coutinho R; Krol A; Prins M
    Clin Gastroenterol Hepatol; 2011 Sep; 9(9):786-792.e1. PubMed ID: 21699803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in siblings of patients coinfected with HIV and hepatitis C virus.
    Hansen AB; Gerstoft J; Kronborg G; Pedersen C; Sorensen HT; Obel N
    J Infect Dis; 2007 Jan; 195(2):230-5. PubMed ID: 17191168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture risk in hepatitis C virus infected persons: results from the DANVIR cohort study.
    Hansen AB; Omland LH; Krarup H; Obel N;
    J Hepatol; 2014 Jul; 61(1):15-21. PubMed ID: 24650694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.
    Rodger AJ; Roberts S; Lanigan A; Bowden S; Brown T; Crofts N
    Hepatology; 2000 Sep; 32(3):582-7. PubMed ID: 10960453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
    Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
    J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study.
    Hansen N; Obel N; Christensen PB; Krarup H; Laursen AL; Clausen MR; Lunding S; Møller A; Schlichting P; Kromann-Andersen H; Bukh J; Weis N;
    J Viral Hepat; 2009 Sep; 16(9):659-65. PubMed ID: 19486467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
    Deterding K; Tegtmeyer B; Cornberg M; Hadem J; Potthoff A; Böker KH; Tillmann HL; Manns MP; Wedemeyer H
    J Hepatol; 2006 Dec; 45(6):770-8. PubMed ID: 17034895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
    Walter SR; Thein HH; Amin J; Gidding HF; Ward K; Law MG; George J; Dore GJ
    J Hepatol; 2011 May; 54(5):879-86. PubMed ID: 21145812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher clearance of hepatitis C virus infection in females compared with males.
    Bakr I; Rekacewicz C; El Hosseiny M; Ismail S; El Daly M; El-Kafrawy S; Esmat G; Hamid MA; Mohamed MK; Fontanet A
    Gut; 2006 Aug; 55(8):1183-7. PubMed ID: 16434426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
    Prasad L; Spicher VM; Negro F; Rickenbach M; Zwahlen M;
    J Viral Hepat; 2009 Sep; 16(9):644-9. PubMed ID: 19243494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.